Phase 2 Study of TLK286 in Metastatic Breast Cancer

Status:
Completed

Trial end date:
2004-07-01

Target enrollment:

Participant gender:

The purpose of this study is to determine the effectiveness of TLK286 in treatment of metastatic breast cancer.

Phase 2

Telik